Giles® is thrilled to announce a successful funding round in which the company raised $750,000, marking a significant milestone in its mission to revolutionize the healthcare landscape. This capital infusion underscores the confidence investors have in Giles®' innovative approach to transforming everyday processes across pharma, biotech, hospitals, clinical research, and public health. Founded with the ambition to ease the burdens faced by those working tirelessly in labs, academia, and boardrooms alike, Giles® is dedicated to taking on the heavy lifting so healthcare professionals can focus on delivering cutting-edge care and groundbreaking research. With this latest round of funding, Giles® is set to broaden its suite of technological solutions, further empowering its clients to make smarter, faster decisions in an ever-evolving industry. The funds will be strategically allocated towards enhancing the company’s existing platforms, scaling up operations, and continuing vital research and development programs that pave the way for next-generation healthcare innovations. As the company continues to make life easier for the many individuals who keep the healthcare ecosystem moving forward, the new investment ignites a renewed commitment to excellence and forward-thinking transformation. With Giles® now at the forefront of digital solutions, their pioneering work is set to redefine industry standards and equip healthcare professionals with the tools they need to thrive in a dynamic environment. This recent injection of capital is not merely a financial milestone—it is a tangible endorsement of Giles®' vision to create a smarter, faster, and more responsive future for healthcare worldwide.
Giles AI Secures $750K in Pre-Seed Funding, Driving the Healthcare Revolution
Recently funded · £750.0K Pre-seedAI-powered assistant
Get the full Giles AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Dognosis India | Pre-seed | $1.5M | today |
| 2 | Dognosis India | Pre-seed | $1.5M | today |
